Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

October 19, 2020, the 83rd China International Medical Equipment Fair (CMEF) and the 30th International Component Manufacturing & Design Show (ICMD) opened in National Exhibition and Convention Center (Shanghai).

Reported by CCTV news on Oct. 16th, variety of countries need to enlarge the test method to speed up the diagnosis on COVID-19. Some of the countries used the faster and cheaper test methods to overcome the bottleneck of inadequate capabilit

Shenzhen New Industries Biomedical Engineering Co., LTD., which was officially listed on the Gem of Shenzhen Stock Exchange on May 12, 2020,realized 97,0101,600 yuan of revenue, an increase of 31.06% over the same period last year.

Mindray is expected to achieve the operating income of 14.855 billion yuan to 16.093 billion yuan in the first three quarters of 2020, a year-on-year growth of 20% to 30%; Kehua announced that the company expects the net profit of the first

On Sep. 25th, Upper Biotech applied for IPO was accepted by Shanghai Stock Exchange. At present, it has 7 listed enterprise on STAR Market, 2 registered upcoming companies and 5 waitings.

October 9, with the endorsement of Premier Li Keqiang, the State Council issued the Opinions on Further Improving the Quality of Listed Companies (hereinafter referred to as the Opinions).

From August to September 2020, the COVID-19 testing products of 5 companies around the world are included in the World Health Organization (WHO) Emergency Use Listing (the full English name is "Emergency Use Listing", "EUL" for short), of wh

From July to September, eight Chinese in vitro diagnostic companies have successively obtained Emergency Use Authorization(EUA) issued by US Food and Drug Administration (FDA) .

NGS cancer companion diagnostics is an emerging industry in China, and its industry concentration has gradually increased over the past 6 years around development.

The Supreme Law and the National Medical Insurance Bureau issued a document: From now on, medical commercial bribery cases will be notified to the Medical Insurance Bureau